Skip to main content
. 2023 Jun 5;18(6):1305–1314. doi: 10.1021/acschembio.3c00028

Figure 4.

Figure 4

Optical control of a RASopathy mutant of NRAS. (A) Structural representation of the caged NRAS nucleotide-binding site before and after light exposure (models generated from PDB: 5UHV). (B) Diagram of the general RAS/MAPK signaling pathway. (C) Western blot of ACK incorporation into HA-NRAS G60E K16TAG (NRAS-ACK). (D) Western blot of phospho-ERK at different timepoints after irradiation of NRAS-ACK. NT = nontreated embryos.